PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of jexpmedHomeThe Rockefeller University PressEditorsContactInstructions for AuthorsThis issue
 
J Exp Med. 1952 January 1; 95(1): 71–97.
PMCID: PMC2212053

A MUCOPROTEIN DERIVED FROM HUMAN URINE WHICH REACTS WITH INFLUENZA, MUMPS, AND NEWCASTLE DISEASE VIRUSES

Abstract

A mucoprotein, present in normal human urine, has been isolated and obtained in a state of a high degree of purity. A number of the biological, chemical, and physicochemical properties of the substance have been studied. From the results obtained in the present investigation and those reported in succeeding papers (34, 35) it appears that the mucoprotein has a high molecular weight, i.e., of the order of 7.0 x 106, consists of thread-like molecules which have axial ratios of approximately 100, and is specifically antigenic. This substance, which appears to be free of contaminating material, possesses in extraordinary degree the capacity to react with influenza, mumps, and Newcastle disease viruses. At equilibrium, with influenza virus, the minimal amount of the substance capable of giving a demonstrable reaction with one hemagglutinating unit of virus appears to be about 0.0003 µg. The mucoprotein is altered by preparations of influenza viruses and its capacity to react with these agents or others is lost. The kinetics of the inactivation process brought about by influenza viruses is in accord with those of well known enzyme-substrate systems. With the exception of the capacity to react with viruses, altered mucoprotein did not differ from the native substance relative to any of the properties examined in the present study. That certain physicochemical properties of the altered mucoprotein are different from those of the native substance is demonstrated in succeeding papers (34, 35).

Full Text

The Full Text of this article is available as a PDF (1.4M).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Hirst GK. THE AGGLUTINATION OF RED CELLS BY ALLANTOIC FLUID OF CHICK EMBRYOS INFECTED WITH INFLUENZA VIRUS. Science. 1941 Jul 4;94(2427):22–23. [PubMed]
  • Friedewald WF, Miller ES, Whatley LR. THE NATURE OF NON-SPECIFIC INHIBITION OF VIRUS HEMAGGLUTINATION. J Exp Med. 1947 Jun 30;86(1):65–75. [PMC free article] [PubMed]
  • Deburgh PM, Yu PC, Howe C, Bovarnick M. PREPARATION FROM HUMAN RED CELLS OF A SUBSTANCE INHIBITING VIRUS HEMAGGLUTINATION. J Exp Med. 1948 Jan 1;87(1):1–9. [PMC free article] [PubMed]
  • HARDY PH, Jr, HORSFALL FL., Jr Reactions between influenza virus and a component of allantoic fluid. J Exp Med. 1948 Oct 1;88(4):463–484. [PMC free article] [PubMed]
  • ADA GL, STONE JD. Electrophoretic studies of virus-red cell interaction: mobility gradient of cells treated with viruses of the influenza group and the receptor-destroying enzyme of V. cholerae. Br J Exp Pathol. 1950 Jun;31(3):263–274. [PubMed]
  • STONE JD, ADA GL. Electrophoretic studies of virus-red cell interaction: additive effect of viruses of the influenza group and the receptor-destroying enzyme of V. cholerae. Br J Exp Pathol. 1950 Jun;31(3):275–284. [PubMed]
  • Hirst GK. ADSORPTION OF INFLUENZA HEMAGGLUTININS AND VIRUS BY RED BLOOD CELLS. J Exp Med. 1942 Aug 1;76(2):195–209. [PMC free article] [PubMed]
  • HIRST GK. The nature of the virus receptors of red cells; the effect of partial heat inactivation of influenza virus on the destruction of red cell receptors and the use of inactivated virus in the measurement of serum inhibitor. J Exp Med. 1948 Apr 1;87(4):315–328. [PMC free article] [PubMed]
  • Francis T. DISSOCIATION OF HEMAGGLUTINATING AND ANTIBODY-MEASURING CAPACITIES OF INFLUENZA VIRUS. J Exp Med. 1947 Jan 1;85(1):1–7. [PMC free article] [PubMed]
  • LANNI F, SHARP DG, et al. The egg white inhibitor of influenza virus hemagglutination; preparation and properties of semipurified inhibitor. J Biol Chem. 1949 Jul;179(3):1275–1287. [PubMed]
  • GOTTSCHALK A, LIND PE. Ovomucin, a substrate for the enzyme of influenza virus; ovomucin as an inhibitor of haemagglutination by heated Lee virus. Br J Exp Pathol. 1949 Apr;30(2):85–92. [PubMed]
  • HIRST GK. The nature of the virus receptors of red cells; partial purification of the virus agglutination inhibitor in human plasma. J Exp Med. 1949 Feb;89(2):223–232. [PMC free article] [PubMed]
  • LANNI F, LANNI YT, BEARD JW. Inhibitory effect of cow's milk on influenza virus hemagglutination. Proc Soc Exp Biol Med. 1949 Oct;72(1):227–232. [PubMed]
  • Hirst GK. ADSORPTION OF INFLUENZA VIRUS ON CELLS OF THE RESPIRATORY TRACT. J Exp Med. 1943 Aug 1;78(2):99–109. [PMC free article] [PubMed]
  • TAMM I, HORSFALL FL., Jr Characterization and separation of an inhibitor of viral hemagglutination present in urine. Proc Soc Exp Biol Med. 1950 May;74(1):106–108. [PubMed]
  • PERLMANN GE, TAMM I, HORSFALL FL., Jr An electrophoretic examination of a urinary mucoprotein which reacts with various viruses. J Exp Med. 1952 Jan;95(1):99–104. [PMC free article] [PubMed]
  • Rapoport S, Wing M. DIMENSIONAL, OSMOTIC, AND CHEMICAL CHANGES OF ERYTHROCYTES IN STORED BLOOD. I. BLOOD PRESERVED IN SODIUM CITRATE, NEUTRAL, AND ACID CITRATE-GLUCOSE (ACD) MIXTURES. J Clin Invest. 1947 Jul;26(4):591–615. [PMC free article] [PubMed]
  • GOTTSCHALK A. N-substituted isoglucosamine released from mucoproteins by the influenza virus enzyme. Nature. 1951 May 26;167(4256):845–847. [PubMed]
  • Mehl JW, Oncley JL, Simha R. VISCOSITY AND THE SHAPE OF PROTEIN MOLECULES. Science. 1940 Aug 9;92(2380):132–133. [PubMed]
  • FREDERICQ E, DEUTSCH HF. Studies on ovomucoid. J Biol Chem. 1949 Dec;181(2):499–510. [PubMed]
  • SMITH EL, BROWN DM, WEIMER HE, WINZLER RJ. Sedimentation, diffusion, and molecular weight of a mucoprotein from human plasma. J Biol Chem. 1950 Aug;185(2):569–575. [PubMed]
  • Ogston AG, Stanier JE. On the state of hyaluronic acid in synovial fluid. Biochem J. 1950 Mar;46(3):364–376. [PubMed]
  • Friedewald WF, Pickels EG. CENTRIFUGATION AND ULTRAFILTRATION STUDIES ON ALLANTOIC FLUID PREPARATIONS OF INFLUENZA VIRUS. J Exp Med. 1944 Mar 1;79(3):301–317. [PMC free article] [PubMed]
  • Eckert EA, Lanni F, Beard D, Beard JW. Effect of Swine Influenza Virus on the Viscosity of the Egg-white Inhibitor of Hemagglutination. Science. 1949 May 6;109(2836):463–464. [PubMed]
  • SHARP DG, LANNI F, LANNI YT, BEARD JW. The egg white inhibitor of influenza virus hemagglutination. VI. Sedimentation studies. Arch Biochem. 1951 Feb;30(2):453–465. [PubMed]
  • SHARP DG, LANNI F, LANNI YT, CSAKY TZ, BEARD JW. The egg white inhibitor of influenza virus hemagglutination. V. Electrophoretic studies. Arch Biochem. 1951 Feb;30(2):251–260. [PubMed]
  • STONE JD. Inhibition of influenza virus haemagglutination by mucoids; conversion of virus to indicator for inhibitor. Aust J Exp Biol Med Sci. 1949 Jul;27(4):337–352. [PubMed]
  • Swift HF, Wilson AT, Lancefield RC. TYPING GROUP A HEMOLYTIC STREPTOCOCCI BY M PRECIPITIN REACTIONS IN CAPILLARY PIPETTES. J Exp Med. 1943 Aug 1;78(2):127–133. [PMC free article] [PubMed]
  • Knight CA. PRECIPITIN REACTIONS OF HIGHLY PURIFIED INFLUENZA VIRUSES AND RELATED MATERIALS. J Exp Med. 1946 Mar 31;83(4):281–294. [PMC free article] [PubMed]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press